Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
The Laryngoscope|July 11, 2006
Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding studyClaus Wittekindt, Wei-Chi Liu, Simon F Preuss, et al.
The Laryngoscope|June 4, 2008
Evaluation of peripheral vocal cord paralysis by electromyographyMaria Grosheva, Claus Wittekindt, Claus Pototschnig, et al.
Journal of Cancer Research and Clinical Oncology|September 26, 2012
Prognostic impact of pretherapeutic laboratory values in head and neck cancer patientsFranziska Peter, Claus Wittekindt, Mira Finkensieper, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|April 25, 2012
Postoperative pain assessment after functional endoscopic sinus surgery (FESS) for chronic pansinusitisMira Finkensieper, Katharina Poller, Claus Wittekindt, et al.
Cancer Medicine|March 2, 2019
A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in GermanyMiriam Reuschenbach, Ingeborg Tinhofer, Claus Wittekindt, et al.
Head & Neck|June 15, 2007
Recurrent pleomorphic adenoma of the parotid gland: analysis of 108 consecutive patientsClaus Wittekindt, Kristina Streubel, Georg Arnold, et al.
Head & Neck|January 16, 2004
Botulinum toxin type A for the treatment of chronic neck pain after neck dissectionClaus Wittekindt Vasan, Wei-Chi Liu, Jens-Peter Klussmann, et al.
The Laryngoscope|January 8, 2004
Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical studyEberhard Stennert, Claus Wittekindt, Jens Peter Klussmann, et al.
The Annals of Otology, Rhinology, and Laryngology|November 27, 2002
Complications of suspension laryngoscopyJens Peter Klussmann, Robert Knoedgen, Claus Wittekindt, et al.
The Annals of Otology, Rhinology, and Laryngology|April 1, 2004
Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: need for a clinical trial?Ursula Schröder, Volker Dries, Jens Peter Klussmann, et al.
Pageof 10